Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of N-acetylcysteine on cognitive performance impairment in bipolar disorder
IRCT20220516054879N7Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in bipolar disorder (BD) and confusion, sponsored by Guilan University of Medical Sciences. Started May 2023; status: completed.
02
Drugs
acetylcysteine
03
Conditions
bipolar disorder (BD)confusion
Beyond the preview
Go deeper on IRCT20220516054879N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220516054879N7.